Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Image: Mindray DP-50 Digital Ultrasonic Diagnostic Imaging System (Photo courtesy of Mindray)

Lung Ultrasound Better Than Chest X-Ray for Diagnosis of COVID-19, Finds Study

A new study has found that portable ultrasound scans are more sensitive than X-rays for the preliminary detection of atypical pneumonia in patients who may have COVID-19. More...
11 Nov 2020
Image: T-SPOT Discovery SARS-CoV-2 assay (Photo courtesy of Oxford Immunotec)

T-Cells May Be Sufficient to Provide Protection from COVID-19, Finds New Study

Data released from a prospective cohort study in key workers in the UK demonstrates that SARS-CoV-2 reactive T cells may be sufficient to give protection from COVID-19 and that serology alone may underestimate those at lower risk of clinical SARS-CoV-2 infection. More...
11 Nov 2020
Image: Qiagen and TScan Therapeutics to Jointly Develop T Cell-Based Laboratory Test for COVID-19 Immune Response (Photo courtesy of TScan Therapeutics)

Qiagen and TScan Therapeutics to Jointly Develop T Cell-Based Laboratory Test for COVID-19 Immune Response

 QIAGEN N.V. (Venlo, Netherlands) and TScan Therapeutics (Waltham, MA, USA) have entered into a research license and option agreement to develop T cell-based laboratory tests for detecting prior exposure to the novel coronavirus, SARS-CoV-2, using discoveries from TScan’s high-throughput TCR/Target discovery platform, T-Scan. More...
11 Nov 2020
Image: CareStart COVID-19 Antigen Rapid Point-of-Care test kit (Photo courtesy of AccessBio)

Stand-Alone COVID-19 Rapid POC Antigen Test Delivers Results in 10 Minutes Without Separate Analyzer

A new minimally-invasive, stand-alone COVID-19 POC antigen test delivers rapid results in 10 minutes without the need for a separate analyzer. More...
11 Nov 2020
Image: Pfizer Coronavirus Vaccine More Than 90% Effective in Preventing COVID-19 in Phase 3 Study (Photo courtesy of CDC)

Pfizer Coronavirus Vaccine More Than 90% Effective in Preventing COVID-19 in Phase 3 Study

Pfizer Inc. (New York, NY, USA) and Biopharmaceutical New Technologies (BioNTech Mainz, Germany) have announced that their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection. More...
10 Nov 2020
Illustration

Lung Ultrasound Scan Findings Can Help Identify False-Negative COVID-19 Test Results

A new study has found that the integration of lung ultrasound (LUS) with clinical evaluation is associated with increased sensitivity for the diagnosis of COVID-19 pneumonia, and may facilitate the identification of false negative SARS-CoV-2 RT-PCR results. More...
10 Nov 2020
Image: Researchers Use Physics Technology to Develop Rapid Antigen COVID-19 Test (Photo courtesy of MIT)

Researchers Use Physics Technology to Develop Rapid Antigen COVID-19 Test

Researchers have adapted technology that is typically used for physics applications to create a rapid antigen COVID test that has been able to detect viral proteins in minutes with high accuracy. More...
10 Nov 2020
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Monitor/Defibrillator
Zenix
Digital Radiography System (Ceiling Free)
Digix CF Series
Copyright © 2000-2026 Globetech Media. All rights reserved.